Latest Pivotal bioVenture Partners Investment Advisor LLC Stock Portfolio

$307Million | No. of Holdings #13

Pivotal bioVenture Partners Investment Advisor LLC Performance

2026 Q2-1.21%
YTD+8.65%
2025+25.79%

About Pivotal bioVenture Partners Investment Advisor LLC and 13F Hedge Fund Stock Holdings

On 2026-08-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Pivotal bioVenture Partners Investment Advisor LLC reported an equity portfolio of $307.8 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, ARQT, TRVI. The fund has invested 26.9% of it's portfolio in VAXCYTE INC and 10.8% of portfolio in ARCUTIS BIOTHERAPEUTICS INC. <br><br> The fund managers got completely rid off BOLT BIOTHERAPEUTICS INC (BOLT) stocks. They significantly reduced their stock positions in ZENAS BIOPHARMA INC and ARCUTIS BIOTHERAPEUTICS INC (ARQT). Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in AVALYN PHARMACEUTICALS INC. The fund showed a lot of confidence in some stocks as they added substantially to AVALO THERAPEUTICS INC (AVTX), TREVI THERAPEUTICS INC (TRVI) and VAXCYTE INC (PCVX).
Pivotal bioVenture Partners Investment Advisor LLC Equity Portfolio Value
Last Reported on: 13 Aug, 2026
$307Million
  as of Aug 13, 2026

Pivotal bioVenture Partners Investment Advisor LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Pivotal bioVenture Partners Investment Advisor LLC made a return of -1.21% in the last quarter. In trailing 12 months, it's portfolio return was 64.06%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
avalyn pharmaceuticals inc31,826,800

New stocks bought by Pivotal bioVenture Partners Investment Advisor LLC

Additions

Ticker% Inc.
avalo therapeutics inc46.67
trevi therapeutics inc12.16
vaxcyte inc3.87

Additions to existing portfolio by Pivotal bioVenture Partners Investment Advisor LLC

Reductions

Ticker% Reduced
zenas biopharma inc-17.1
oculis holding ag-10.36
arcutis biotherapeutics inc-6.68
maplight therapeutics inc0.00

Pivotal bioVenture Partners Investment Advisor LLC reduced stake in above stock

Sold off

Ticker$ Sold
bolt biotherapeutics inc-172,027

Pivotal bioVenture Partners Investment Advisor LLC got rid off the above stocks

Sector Distribution

Pivotal bioVenture Partners Investment Advisor LLC has about 58.2% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare58.2
Others41.8

Market Cap. Distribution

Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • MICRO-CAP
Category%
MID-CAP53.3
UNALLOCATED41.8
SMALL-CAP3.3
MICRO-CAP1.6

Stocks belong to which Index?

About 50.5% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200050.5
Others49.5
Top 5 Winners (%)%
RLYB
rallybio corp
78.4 %
maplight therapeutics inc
76.3 %
TRVI
trevi therapeutics inc
51.7 %
bioage labs inc
40.1 %
zenas biopharma inc
27.3 %
Top 5 Winners ($)$
TRVI
trevi therapeutics inc
11.1 M
maplight therapeutics inc
9.5 M
bioage labs inc
4.6 M
ARQT
arcutis biotherapeutics inc
3.5 M
zenas biopharma inc
3.2 M
Top 5 Losers (%)%
oculis holding ag
-45.4 %
evommune inc
-42.2 %
IMNM
immunome inc
-3.1 %
Top 5 Losers ($)$
oculis holding ag
-20.3 M
evommune inc
-18.7 M
IMNM
immunome inc
-0.5 M

Pivotal bioVenture Partners Investment Advisor LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC

Pivotal bioVenture Partners Investment Advisor LLC has 13 stocks in it's portfolio. About 95.1% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. TRVI was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.

$307.79MTotal Value
14.00Positions
13 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC, last reported on 13 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
Com Shs
Avalyn Pharmaceuticals Inc

Avalyn Pharmaceuticals Inc

Pivotal bioVenture Partners Investment Advisor LLC's holding in Avalyn Pharmaceuticals Inc over time
10.34%966,792
$31.83M
10.34%
new position
Com Shs
Evommune Inc

Evommune Inc

Pivotal bioVenture Partners Investment Advisor LLC's holding in Evommune Inc over time
8.32%1,926,940
$25.61M
8.32%
unchanged 0 percentunchanged
Com
Maplight Therapeutics Inc

Maplight Therapeutics Inc

Pivotal bioVenture Partners Investment Advisor LLC's holding in Maplight Therapeutics Inc over time
7.12%611,446
$21.91M
7.12%
unchanged 0 percentreduced
Ordinary Shares
Oculis Holding Ag

Oculis Holding Ag

Pivotal bioVenture Partners Investment Advisor LLC's holding in Oculis Holding Ag over time
6.79%1,506,250
$20.89M
6.79%
decreased 10.36 percentreduced
Com
Bioage Labs Inc

Bioage Labs Inc

Pivotal bioVenture Partners Investment Advisor LLC's holding in Bioage Labs Inc over time
5.2%653,374
$16.01M
5.2%
unchanged 0 percentunchanged
Com
Zenas Biopharma Inc

Zenas Biopharma Inc

Pivotal bioVenture Partners Investment Advisor LLC's holding in Zenas Biopharma Inc over time
4.05%490,766
$12.46M
4.05%
decreased 17.1 percentreduced